Navigation Links
Autism Speaks Applauds Supreme Court Decision Upholding Families' Right to Challenge IEPs Without First Trying Out School District Proposed Placement
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire/ -- By a vote of 4-4, the Supreme Court today upheld the Second Circuit Court decision in the case of Board of Education of City of New York v. Tom F., 06-637, thereby affirming parents' statutory right to challenge a school district's Individualized Education Plan (IEP) without first "trying out" the school district's proposed placement. The New York City Department of Education had argued that even if the child's IEP is demonstrably inappropriate, a parent should not have standing to challenge their child's IEP unless the parent has first "tried out" the school district's IEP.

"Today the court affirmed the danger of making students try out an inappropriate school district program. Students who need early intervention do not have time to waste," said Gary Mayerson, an Autism Speaks board member and founder of law firm Mayerson & Associates. "School districts need to fulfill their statutory responsibility to create an appropriate IEP for every child with a disability or to pay for that student to attend an appropriate private school."

Autism Speaks filed an amicus brief in the case, focusing on the critical nature of early intervention for children with autism. The brief explained why parents of children with autism should not be forced to "try out" demonstrably inappropriate and ineffective IEP programs during what may well be a relatively narrow window of opportunity. Justice Ruth Bader Ginsburg quoted from the brief during oral argument. The brief was prepared as part of The Autism Speaks Federal Legal Appeals Project (FLAP), a national pro bono initiative assembled and directed by Mayerson for Autism Speaks. To date, approximately ten national profile law firms, including Akin Gump Strauss Hauer & Feld, have joined the FLAP committee with commitments to provide significant pro bono legal services at the federal level. Akin Gump attorneys Robert H. Pees, Michael D. Lockard, Amanda R. Johnson, Sunish Gulati and Ev
'/>"/>

SOURCE Autism Speaks
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Antibiotics Helps Autism
2. Early diagnosis for autism from blood tests may be possible
3. Latest discovery on Autism
4. Resolving Autism
5. Studying The Causes Of Autism
6. Mercury Pollution Linked To Rise In Autism
7. Early identification of autism possible
8. Autism risks linked to birth factors
9. Autism epidemic is a myth- says a new study
10. Treating Autism More Effectively
11. MMR Vaccination not linked to Autism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ire/--NIP,Inc.todayannouncedtheacquisitionofRetire...cutivecompensationandbenefitplanprovidersheadquart...sAngeles,Milwaukee,Boston,ChicagoandAtlanta.RCGwas...heexecutivebenefitsindustry. ,, "Weareexcitedto...antmarketpresence,"statesBillPollock,ChairmanandFo...
(Date:11/24/2009)...ire-USNewswire/--Dr.NelsonEscobar,aphysicianwithth...heJamesBradyAward.TheawardwaspresentedtohimbytheBr...alconferenceonOctober30,2009. ,, Accordingtothe...ionofhisexpertiseinaddressingthecomplexneedsofpers...xceptionalcareofhispatientsandtheirfamiliesastheyr...
(Date:11/24/2009)...FirstCall/--CenteneCorporation(NYSE: CNC )todayann...tedCenteneasoneoftwoCoordinatedCareOrganizationsto...k(MississippiCAN),acoordinatedcareprogramforMissis...Divisiontoexecuteacontractinwhichthecompanywillser...thPlan(Magnolia). ,, BasedinJackson,Miss.,Magno...
(Date:11/24/2009)...er greatly between high- and low-volume centers, s...ay News) -- Do hospitals that conduct the most ang...r patients? Maybe not. , Prior research had sug... to artery-opening procedures, but a new study inv...lume hospitals performing more or less equally. ,...
(Date:11/24/2009)...nds no added use but higher costs , , TU...mer drug ads may contribute to higher Medicaid cos...f the widely used antiplatelet drug clopidogrel (P...5 for 27 state Medicaid programs found that direct...ncrease people,s use of the drug but appeared to b...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Advertising to Consumers May Raise Drug Prices 2
...21, 2008 A recent study shows that pre-operative a...cal therapists allow for early diagnosis and succe...cted by the National Naval Medical Center (NNMC) a...e journal, Cancer (April 25, 2008). The authors d...
..., discomfort may be driving factor, study suggests...eople with asthma may be at increased risk for sui... suicidal thoughts without suicide attempts, accor...der, from the U.S. National Comorbidity Survey Rep...
... REVERSE MENTAL ACUITY DEFICITS IN SMOKERS WHO,ARE...view to Address FAA,Ruling on Smoking Cessation Pr... Federal Aviation,Administration (FAA) that it has...this news does not include NRT, which,is deemed sa...
...subgroup of participants in the Womens Health Init...sts that healthy, postmenopausal women whose blood... increased, short-term risk for heart attack when ...) cholesterol to high-density lipoprotein (HDL, or...
...er cells from embryonic stem cells, find clues to ...y 23 (HealthDay News) -- Human liver cells have be... model, hopefully opening the door to help scienti...s that were presented this week at Digestive Disea...
...ompanies establishing online personal health recor...king robotic surgery routine, it makes sense to ha...ursing staff, care managers and other healthcare w...stem. , Akio Koyama of Yamagata University, Japan...
Other Medicine News:Health News:New study shows positive role physical therapists play in lymphedema diagnois and treatment 2Health News:Asthma Associated With Suicidal Thoughts, Attempts 2Health News:MultiVu Video Feed: FREE NICOTINE REPLACEMENT THERAPY (NRT) TO BE OFFERED TO REGISTERED PILOTS INTERESTED IN QUITTING RELIEF IN LIGHT OF RECENT FAA RULINGS 2Health News:Blood cholesterol levels predict risk of heart disease due to hormone therapy 2Health News:New Hope for Liver Diseases 2Health News:New Hope for Liver Diseases 3Health News:Remote-control health 2
(Date:11/24/2009)...-FirstCall/--Orexigen®Therapeutics,Inc.(Nasda...atmentofobesity,todayannouncedthatonNovember18,200...ctorsgrantedaninducementstockoptiontopurchase200,0...yappointedHeadoftheGlobalContraveProgram. ,, Th...theextentpermittedbylawandhasanexercisepricepersha...
(Date:11/24/2009)...ewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),...mercializingnovelpainmanagementtherapies,todayanno...ors,effectiveNovember19,2009.Mr.Orwinisa20-yearsal...yandhasbeeninstrumentalinthelaunchofseveralimporta...iorVicePresident,BioOncologyBusinessUnitatGenentec...
(Date:11/23/2009)...--TwooftheChicagoarea,sleadingBoardCertifiedDiagno...stimaging,couplingthelatesttechnologyindigitalmamm...bilitytohavethefullrangeofdigitalimagingcompleted,...theoffice.Drs.AhmedFaragandJoanWerberaredelivering...onthwaitforanappointmentcommonlyfoundinChicago,fro...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Next generation software system for flood warning and risk analysis to be developed 8704 1Next generation software system for flood warning and risk analysis to be developed 8704 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 1Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 3Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 4
...nc. (CTI) announces data presented at AACR-NCI-EOR...RANCISCO, Oct. 26 Cell Therapeutics,Inc. (CTI) (N...M), a,wholly-owned subsidiary of CTI, announced ne...ates during the 19th annual AACR-NCI-EORTC Symposi... identifying specific,tumor types with a higher li...
...ch Provides Tolerable and Effective Symptom Contro...SHPGY, TSX: SHQ), the global specialty biopharmace...h study of DAYTRANA(TM) (methylphenidate,transderm...sorder (ADHD),patch, demonstrated that DAYTRANA pr...ontrol improvement in children aged 6 to 12 years....
Other Medicine Technology:Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5
...ceMate is the industry's most powerful, comprehens...vailable. In fact, OfficeMate is the most widely u...t of every three computerized eyecare businesses u... practice management needs including patient demog...
Winx Pro Practice Management Software for Eyecare Professionals
E-Z Frame Platinum
VitalWorks Intuition PM Ophthalmology
Medicine Products: